FSHB and Azoospermia: In Cohort B, FSHB c.-211 showed a lower prediction rate for cluster membership of patients with crypto- and azoospermia: 81.3% of T-allele carriers were allocated to Cluster 1, and 68.8% of wildtype patients were assigned to Cluster 2.